Healius CEO exits as strategic review speeds up Maxine Jaquet is departing Australia’s second-largest pathology company. Analysts think its imaging operations could be sold. PwC spin-off Scyne appoints start-up founder Claudine Ogilvie as its sixth and final board member.
#HEALTH #English #IL
Read more at The Australian Financial Review